These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adrenal incidentalomas and subclinical Cushing's syndrome: is there evidence for glucocorticoid-induced osteoporosis? Angeli A, Osella G, Reimondo G, Terzolo M. Front Horm Res; 2002 Jan; 30():73-85. PubMed ID: 11892272 [No Abstract] [Full Text] [Related]
3. The adrenal cortex. I. Historical aspects. II. Clinical considerations. Thorn GW. Johns Hopkins Med J; 1968 Aug; 123(2):49-77. PubMed ID: 4299164 [No Abstract] [Full Text] [Related]
4. Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency. Jeffcoate W. Ann Clin Biochem; 1999 Mar; 36 ( Pt 2)():151-7. PubMed ID: 10370729 [Abstract] [Full Text] [Related]
6. [Clinical deterioration of 4 of 5 cases of Cushing's syndrome after administration of STC 407]. Köbberling J, zur Mühlen A von, Hüfner M. Acta Endocrinol Suppl (Copenh); 1971 Nov; 152():92. PubMed ID: 5313716 [No Abstract] [Full Text] [Related]
7. Treatment of diseases of the adrenal cortex affecting growth and development. Wegienka LC, Forsham PH. Mod Treat; 1968 Jan; 5(1):168-83. PubMed ID: 4873499 [No Abstract] [Full Text] [Related]
8. Medical management of adrenal disease: a narrative review. Michalakis K, Ilias I. Endocr Regul; 2009 Jul; 43(3):127-35. PubMed ID: 19817507 [Abstract] [Full Text] [Related]
9. [Attempt at prolonged stimulation of adrenocortical insufficiency by long-acting beta-1-24-corticotrophin]. Luton JP, Slama G, Turpin G, Bricaire H. Rev Fr Endocrinol Clin; 1972 Jul; 13(5):425-34. PubMed ID: 4352282 [No Abstract] [Full Text] [Related]
10. [The collateral effects of prolonged corticosteroid therapy]. Genova R. Minerva Pediatr; 1969 Oct 27; 21(43):2026-38. PubMed ID: 4326808 [No Abstract] [Full Text] [Related]
12. Some observations on the hazards of corticosteroid therapy in patients with inflammatory bowel disease. Goldstein MJ, Gelzayd EA, Kirsner JB. Trans Am Acad Ophthalmol Otolaryngol; 1967 Oct 27; 71(2):254-61. PubMed ID: 4292814 [No Abstract] [Full Text] [Related]
13. [New data on the pathogenesis of steroid-induced osteoporosis: consequences for therapy and prevention]. Hüfner M, Siggelkow H. Dtsch Med Wochenschr; 2003 Jul 25; 128(30):1602-8. PubMed ID: 12884149 [No Abstract] [Full Text] [Related]
16. [Functional exploration of the adrenal cortex in basal and dynamic conditions in hypercorticism of the Cushing type]. Minozzi M, Faggiano M, Salerno M, Lombardi G, Nunziata V. Folia Endocrinol; 1968 Jun 25; 21(3):292-311. PubMed ID: 4304524 [No Abstract] [Full Text] [Related]
17. Medical management of adrenal cortical disease. Paulson DF. Urol Clin North Am; 1977 Jun 25; 4(2):297-304. PubMed ID: 898415 [No Abstract] [Full Text] [Related]
18. On the mechanism of action of carbohydrate active steroids on tastant detection and recognition. Henkin RI, Bradley DF. UCLA Forum Med Sci; 1972 Jun 25; 15():339-53. PubMed ID: 5080611 [No Abstract] [Full Text] [Related]
19. [Treatment of glycoactive hypercorticism]. Jacobelli A, Agostino A, Altomonte G. Clin Ter; 1984 Nov 30; 111(4):367-72. PubMed ID: 6098404 [No Abstract] [Full Text] [Related]